EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis and pharmacological evaluation of phenylthiophene-2-carboxamide-based RSV fusion protein inhibitors

Muhammad Kashif Zaman, Chunguang Yang, Fengming He, Chuang He, Qiubao Wu, Hongxia Zhou, Zifeng Yang, Yingjun Li

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.109690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Muhammad Kashif Zaman und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Joi…. Hauptthemen laut MEDLINE: Thiophenes, Antiviral Agents, Drug Design, Respiratory Syncytial Viruses. Die Arbeit nennt 88 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) remains a significant cause of serious lower respiratory tract infection, highlighting the urgent need for new antivirals. A series of amide bond containing fluorinated benzimidazole derivatives was synthesized, and substitution of the N-phenylcarboxamide moiety with five-membered heteroaryl groups led to enhanced potency, with 2- and 3-halogenated thiophene rings significantly improved anti-RSV activity. Structural optimization afforded compound 21, bearing a 3-bromo-N-phenylthiophene-2-carboxamide moiety, which exhibited subnanomolar potency against RSV (IC50 = 0.10 nM). Molecular docking studies suggest compound 21 forms stable hydrogen bonds and π-π stacking interactions with the pre-fusion F protein, providing a mechanistic basis for its activity. Compound 21 dose-dependently suppressed RSV F protein expression in HEp-2 cells and significantly reduced viral burden in the lungs in an RSV-infected murine model. These results identify compound 21 as a highly potent RSV fusion inhibitor and a promising lead for further antiviral development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiophenesAntiviral AgentsDrug DesignRespiratory Syncytial VirusesViral Fusion ProteinsRespiratory Syncytial Virus InfectionsViral Fusion Protein InhibitorsAnimalsHumansStructure-Activity RelationshipMiceDose-Response Relationship, DrugMolecular StructureMolecular Docking SimulationMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Amide bondAntiviralFusion inhibitorsRespiratory syncytial virusThiophene

Substanzen

ThiophenesAntiviral AgentsViral Fusion ProteinsViral Fusion Protein Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Joint International Research Laboratory of Respiratory Health, Guangdong…
  • Guangzhou National Laboratory, Guangzhou, Guangdong 510005, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zaman, M. K., Yang, C., He, F., He, C., Wu, Q., Zhou, H., Yang, Z., & Li, Y. (2026). Design, synthesis and pharmacological evaluation of phenylthiophene-2-carboxamide-based RSV fusion protein inhibitors. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109690

Vancouver

Zaman MK, Yang C, He F, He C, Wu Q, Zhou H, et al. Design, synthesis and pharmacological evaluation of phenylthiophene-2-carboxamide-based RSV fusion protein inhibitors. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109690

BibTeX
@article{Zaman2026,
  author = {Zaman, Muhammad Kashif and Yang, Chunguang and He, Fengming and He, Chuang and Wu, Qiubao and Zhou, Hongxia and Yang, Zifeng and Li, Yingjun},
  title = {Design, synthesis and pharmacological evaluation of phenylthiophene-2-carboxamide-based RSV fusion protein inhibitors},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.109690}
}
Kostenlos starten →